The ASC - Autism Pilot Study is a single center randomized open dose titrating phase I
clinical intervention pilot trial with the aim of investigating safety and treatment effect
of an allogeneic adipose tissue derived mesenchymal stromal cell product (C2C_ASC) in
children with autism spectrum disorder (ASD) and gastrointestinal symptoms.